Type your tag names separated by a space and hit enter

Auranofin versus placebo in rheumatoid arthritis

Auranofin versus placebo in rheumatoid arthritis is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

"Auranofin Versus Placebo in Rheumatoid Arthritis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456769/all/Auranofin_versus_placebo_in_rheumatoid_arthritis.
Auranofin versus placebo in rheumatoid arthritis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456769/all/Auranofin_versus_placebo_in_rheumatoid_arthritis. Accessed March 24, 2019.
Auranofin versus placebo in rheumatoid arthritis. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/456769/all/Auranofin_versus_placebo_in_rheumatoid_arthritis
Auranofin Versus Placebo in Rheumatoid Arthritis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456769/all/Auranofin_versus_placebo_in_rheumatoid_arthritis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Auranofin versus placebo in rheumatoid arthritis ID - 456769 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456769/all/Auranofin_versus_placebo_in_rheumatoid_arthritis PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -